Zobrazeno 1 - 10
of 38
pro vyhledávání: '"G. Pelligra"'
Autor:
Laure Gossec, Ana-Maria Orbai, Maarten de Wit, Dafna D Gladman, Laura C Coates, Alexis Ogdie, Vanessa Taieb, Jeremy Lambert, Barbara Ink, Christopher G Pelligra, Valérie Ciaravino
Publikováno v:
RMD Open, Vol 10, Iss 1 (2024)
Objectives To investigate psychometric performance of the 12-item Psoriatic Arthritis Impact of Disease (PsAID-12) total and individual item scores in patients with psoriatic arthritis (PsA) and to estimate score change thresholds and scores correspo
Externí odkaz:
https://doaj.org/article/aa2336a6b90d4afeb287bfb5c55eaac9
Autor:
Lisa J McGarry, Zahra Bhaiwala, Andrea Lopez, Conor Chandler, Christopher G Pelligra, Jaime L Rubin, Theodore G Liou
Publikováno v:
PLoS ONE, Vol 18, Iss 4, p e0283479 (2023)
ObjectivesCystic fibrosis (CF) is a rare genetic disease characterized by life-shortening lung function decline. Ivacaftor, a CF transmembrane conductance regulator modulator (CFTRm), was approved in 2012 for people with CF with specific gene mutatio
Externí odkaz:
https://doaj.org/article/f383c0ab1efb464592cb3b9aa2390bc9
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Niels Rochow, J. Festival, Celia Kwan, Deborah L O'Connor, S. el-Helou, T. Kuehn, A. Wesolowska, B. Poindexter, T. Fu, Amy B. Hair, G. Pelligra, J.-M. Hascoet, Christoph Fusch, Mathias Nelle, Mandy B. Belfort, N. Rochow, Olga Barbarska, G. Fusch, C. Fusch, Miris, Berndt Urlesberger, Gerhard Fusch
Publikováno v:
Clinical Nutrition. 39:2121-2128
Summary Background Human milk analyzers are increasingly used to rapidly measure the macronutrient content in breast milk for individual target fortification, to reduce the risk of postnatal growth restriction. However, many milk analyzers are used w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37a3d5ee2d2a6a2f3926d5b4a23a74f0
https://doi.org/10.1016/j.clnu.2019.08.028
https://doi.org/10.1016/j.clnu.2019.08.028
Autor:
Valeria Santini, Aristoteles Giagounidis, Christopher G. Pelligra, Conrado Franco-Villalobos, Derek Tang, Jessica Morison, CL Beach, Angela Hu, Uwe Platzbecker, Pierre Fenaux
Publikováno v:
Clinical lymphoma, myelomaleukemia. 22(9)
For patients with lower-risk (LR) myelodysplastic syndromes (MDS), overall survival (OS) is rarely a primary clinical trial endpoint. Treatments such as lenalidomide can reduce red blood cell (RBC) transfusion burden (TB) and serum ferritin, but the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3109189255784bfd54a0ac3fc20189f1
https://pubmed.ncbi.nlm.nih.gov/35710702
https://pubmed.ncbi.nlm.nih.gov/35710702
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Shien Guo, Gary Binder, T. Facon, James D. Cavenagh, Darrell White, Andrew R. Belch, C G Pelligra, Yasir Nagarwala, Ariel Berger, Cyrille Hulin, Wai Yiu, Supratik Basu, Saad Z. Usmani, Ajay K. Nooka, Craig J. Gibson, Annette Ervin-Haynes
Publikováno v:
Journal of Medical Economics. 19:243-258
To conduct a cost-effectiveness assessment of lenalidomide plus dexamethasone (Rd) vs bortezomib plus melphalan and prednisone (VMP) as initial treatment for transplant-ineligible patients with newly-diagnosed multiple myeloma (MM), from a U.S. payer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37dc4c763492dd1875d758f33d072fad
https://doi.org/10.3111/13696998.2015.1115407
https://doi.org/10.3111/13696998.2015.1115407
Autor:
Sikander Ailawadhi, Kejal Parikh, Shien Guo, Safiya Abouzaid, Jorge Mouro, Christopher G. Pelligra, C. Chandler
Publikováno v:
Clinical therapeutics. 39(10)
Purpose Pomalidomide plus low-dose dexamethasone (POM-d), daratumumab monotherapy (DARA), and carfilzomib monotherapy (CAR) have been approved for use in the treatment of patients with heavily pretreated relapsed–refractory multiple myeloma (RRMM)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33093147bb6b783956fe3b62043ed1c0
https://pubmed.ncbi.nlm.nih.gov/28967482
https://pubmed.ncbi.nlm.nih.gov/28967482
Autor:
Kenneth T. LaPensee, Nikhil Revankar, Christopher G. Pelligra, T Kongnakorn, Weihong Fan, Alexandra Ward
Publikováno v:
Journal of Medical Economics. 17:730-740
The economic implications from the US Medicare perspective of adopting alternative treatment strategies for acute bacterial skin and skin structure infections (ABSSSIs) are substantial. The objective of this study is to describe a modeling framework
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::593bb04428b04438058a2383fc7d854b
https://doi.org/10.3111/13696998.2014.941065
https://doi.org/10.3111/13696998.2014.941065
Autor:
Alexandra Ward, C. Chandler, Jaime L. Rubin, Jack K Ishak, Michael W. Konstan, Christopher G. Pelligra, Theodore G. Liou, Lasair O’Callaghan
Publikováno v:
Therapeutic Advances in Respiratory Disease
Background: Lumacaftor/ivacaftor combination therapy is efficacious and generally safe for patients with cystic fibrosis (CF) homozygous for the F508del-CF transmembrane conductance regulator (CFTR) mutation. However, long-term survival benefits of l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f91cf982444166414419d41276f72d9
https://doi.org/10.1177/1753466618820186
https://doi.org/10.1177/1753466618820186